№ lp_2_1_18163
File format: docx
Character count: 4435
File size: 193 KB
This document serves as a financial disclosure form for clinical investigators and research team members to declare conflicts of interest and financial arrangements related to clinical studies.
Year:
2026
Region / City:
Not specified
Topic:
Financial disclosure, clinical research
Document Type:
Declaration form
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Clinical investigators, sub-investigators, and research team members
Period of validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Document type:
Application form
Regulatory authority:
South African Health Products Regulatory Authority (SAHPRA)
Country:
South Africa
Subject:
Additions and/or changes in investigators and clinical trial sites
Document number:
GLF-CEM-CT-01D
Related form:
CTF3
Version:
v4
Date of first approval:
October 2019
Date of latest update:
September 2022
Update history:
October 2019 first version approved; March 2020 administrative changes; September 2022 administrative changes, checklist update, appendix removal, document number change
Applicable actions:
Additional investigator(s); Change of investigator(s); Additional site(s); Change in site location
Required attachments:
Cover letter; Investigator documents; Site staff documents; Proof of payment
Approval bodies referenced:
Ethics Committee(s)
Intended applicant:
Sponsor, CRO, or local sponsor company
Regulated area:
Clinical trials
Note:
Year
Topic:
Financial Disclosure
Document Type:
Form
Organization / Institution:
Study Sponsor
Target Audience:
Clinical Investigators, Sub-Investigators
Year:
2024
Region / City:
USA
Topic:
Clinical Research, Regulatory Compliance
Document Type:
Guidance Document
Author:
OVPRI Regulatory Affairs
Target Audience:
Principal Investigators, Research Administrators, Clinical Research Coordinators
Period of Effectiveness:
N/A
Approval Date:
04/25/2024
Amendment Date:
07/09/2024
Description:
Guidance document detailing the steps and regulatory requirements for transferring clinical studies between principal investigators, including documentation updates and approvals required for drug, device, and investigator-initiated studies.
Issuing organization:
National Institutes of Health
Program:
Maximizing Investigators’ Research Award for Early Stage Investigators
Funding mechanism:
R35
Clinical trial policy:
Clinical Trial Optional
Document type:
Application guidance and checklist
Subject area:
Biomedical and behavioral research funding
Target applicants:
Early Stage Investigators
Related documents:
Funding Opportunity Announcement; SF424 (R&R) Research Instructions
Application components:
Forms, narrative attachments, budgets, human subjects and clinical trials information
Formatting requirements:
Font, margins, layout, and hyperlink rules specified
Jurisdiction:
United States
Year:
2023
Region / City:
USA
Subject:
Clinical Research, Financial Disclosure
Document Type:
Form
Organization / Institution:
FDA
Author:
FDA
Target Audience:
Clinical investigators
Effective Period:
Ongoing
Approval Date:
N/A
Date of Changes:
N/A
Year:
2016
Region / city:
Not specified
Subject:
Clinical trial regulations, GCP compliance
Document type:
Checklist
Institution:
Not specified
Author:
Not specified
Target audience:
Investigators, trial staff
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2023
Region / city:
N/A
Topic:
Clinical Trial Consent
Document Type:
Research Protocol
Organization / Institution:
DF/HCC
Author:
N/A
Target Audience:
Parents or Guardians of Children Participating in Clinical Trials
Effective Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
November 2023
Region / City:
London
Topic:
Research Funding
Document Type:
Policy
Organization:
British Heart Foundation
Author:
British Heart Foundation
Target Audience:
Principal Investigators, Co-applicants, Research Staff
Period of Application:
Until 3 months after the grant end date
Approval Date:
November 2023
Date of Changes:
N/A
Year:
2022
Region / City:
London
Topic:
Clinical Trials, Investigational Medicinal Products, Clinical Development
Document Type:
Template
Organization / Institution:
University College London
Author:
University College London
Target Audience:
Clinical researchers, Investigators, Medical professionals involved in Clinical Trials
Effective Date:
02-Mar-2022
Version:
2.0
Period of Validity:
Reviewed annually
Approval Date:
02-Mar-2022
Date of Last Revision:
Not specified
Year:
20XX
Region / City:
Durham, NC
Theme:
Clinical Trials, Investigational Drugs
Organization / Institution:
Duke University
Author:
Not specified
Target Audience:
Investigators, Institutional Review Boards, Ethics Committees
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Note:
Year
Topic:
Financial disclosure, clinical study
Document Type:
Form
Target Audience:
Investigators, Sub-Investigators, Clinical Research Participants
Note:
Year
Year:
2026
Region / City:
Mysuru, Karnataka
Topic:
Public Health, Employment Opportunity
Document Type:
Job Posting
Organization / Institution:
KHPT
Author:
KHPT
Target Audience:
Job Seekers
Period of Action:
2 months
Approval Date:
2026-02-05
Date of Changes:
N/A
Year:
2023
Region / City:
Queensland, Australia
Topic:
Child Protection, Kinship Care
Document Type:
Guidelines
Organization:
Department of Families, Seniors, Disability Services and Child Safety
Author:
Unknown
Target Audience:
Kinship carer applicants, assessors, Child Safety officers
Period of validity:
Not specified
Date of approval:
Not specified
Date of amendments:
Not specified
Year:
2017
Region / City:
NATO Europe
Topic:
Military frequency spectrum allocation
Document Type:
Agreement
Author:
NATO
Target Audience:
NATO Member Nations, Civil and Military Authorities
Period of Validity:
Not specified
Date of Approval:
Not specified
Date of Amendments:
Not specified
Year:
2023
Region / City:
United States
Theme:
Invention Disclosure, Patent Process
Document Type:
Form
Organization:
NIST
Author:
NIST Technology Partnerships Office
Target Audience:
NIST employees, inventors, researchers
Effective Period:
Until submission
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2009
Region / City:
Queensland
Topic:
Criminal History Disclosure, Guide, Hearing, and Assistance Dogs
Document Type:
Legal Guide
Organization / Institution:
Guide, Hearing and Assistance Dogs Team
Author:
Not specified
Target Audience:
People applying for approval as guide, hearing, or assistance dog trainers or employee trainers
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
Not specified
Region / City:
Not specified
Topic:
Author disclosure, conflicts of interest
Document type:
Author disclosure form
Organization / Institution:
Rheumatology
Author:
Not specified
Target audience:
Authors of manuscripts submitted to Rheumatology
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified